International Pharmaceutical Regulatory Harmonization Strategy – Regulatory Science Initiative -
The Ministry of Health, Labour and Welfare (MHLW) has formed the "International Pharmaceutical Regulatory Harmonization Strategy – Regulatory Science Initiative –".
This strategy clarifies Japan's medium- to long-term vision and policy priorities in the sectors of pharmaceuticals, medical devices, etc. in order to more effectively promote initiatives for international harmonization and cooperation under the direction of the Minister of Health, Labour and Welfare.
This strategy aims to demonstrate Japan's proactive leadership in Asia and other regions across the global community. It includes policies such as establishing the "Asian Pharmaceuticals and Medical Devices Regulatory Training Center" within the Pharmaceuticals and Medical Devices Agency (PMDA) to promote understanding of pharmaceutical regulations in Japan by regulatory authority officials in Asia.
In addition, Japan will construct the global action frameworks of the MHLW and PMDA and conduct periodic progress control and necessary reviews of this strategy to promote the initiatives in an ongoing and consistent manner.
＜Materials＞